BK gears up for GLP-1 era with leaner, protein-forward menu tests
Burger King is preparing for a GLP-1 weight-loss drug era by testing leaner, protein-forward items like Whopper Bites and bowls to stay relevant as Americans cut calories. Leadership says they’ll add variety in smaller portions rather than overhauling the menu, while industry forecasts warn of potential revenue losses for food-service. BK’s broader turnaround, “Reclaim the Flame,” and a 5.8% rise in US same-store sales in Q1 signal cautious optimism that fast food can remain convenient, flavorful options even as GLP-1 usage grows.
